Puretech Health Share Discussion Threads

[edwardt] 03/7/2024 14:33

what % are they down to?

[bahiflyer] 03/7/2024 14:17

I'm amazed Invesco still have so many left. They've been drip feeding them down for the last 3 years or so it seems. Rather than buy backs, which did nothing for the share price last time, PRTC should open a dialogue with Invesco to find out what holding they'd be happy to stop selling at and either buy off them direct or find an alternative II to have an interest. That would be much easier to instigate if there was an actual dividend policy, which is after all the only long term way of returning money to shareholders directly, and that's what income funds want, which in turn would stimulate overall share price growth. It's something a decent PR team or advisers would point out to them

[takeiteasy] 03/7/2024 11:35

Perhaps if I wait until year end when Invesco have hopefully cleared down their holding there will be a top up chance?
Until then it is a steepening slide it seems with no support buffers...

nai etc

[takeiteasy] 28/6/2024 16:40

The daily dumpers are clearly guided to sell at any price regardless. If correct, the firm should employ a corporate finance firm to pull all the sellers together and sell at a sensible once off price to an entity who wants a longer term relationship with the firm. Clear them all out in one fell swoop rather than drip, drip and drip etc

[edwardt] 28/6/2024 13:55

topped up just now.

[takeiteasy] 28/6/2024 11:01

Perhaps BOD need to reach out to the shareholder base and ask them what they need to do that might engage with the larger holders to want to commit to their holdings rather than dispose....that is what I might be doing if I was part of the BOD :)

[takeiteasy] 28/6/2024 10:12

where to next I wonder - BOD must be thinking we are utterly wasting our time here to get so trashed for seemingly doing so well with all the biotech research

[brianblu] 28/6/2024 08:40

When you look at the performance of Oxb which was similar a few month back this has been ——-

[takeiteasy] 27/6/2024 16:41

Hopefully that is the end of all the garbage news here - no wonder the traders were so confident shorting this right back...hopefully draw a line now and move on!

[swinsco] 27/6/2024 16:28

Directors selling in the tender offer. You couldn't make it up - how to destroy shareholder value. Clowns

[takeiteasy] 27/6/2024 14:59

Rambutan, yes all good points and I suspect most of here are LTBHs and probably agree ?

[takeiteasy] 27/6/2024 14:57

The chaps trying to knock the door down at 1.90 seem to enjoy hitting their heads against a brick wall as they seem determined to try, try and try again. I nearly picked some up then at 1.86 - just could not commit :)
nai etc

[marvelman] 27/6/2024 14:29

They have spent 100 million in order to knock the share price down to where it was 2 years ago

[marvelman] 27/6/2024 14:26

The BOD seem to be more occupied with feathering their nests judging by the latest RNS's

[takeiteasy] 27/6/2024 14:22

I wonder if any of the BOD will take one for the team over this? Very little AT volume with each push sub 1.90 - they do not seem sure of themselves at this far end of the dip down so are sitting here as long as it takes I guess waiting on retail being stop lossed out :)

[marvelman] 27/6/2024 14:06

Wow,what an utter disaster unfolding here. Shambles does not describe it adequately enough

[ohisay] 27/6/2024 09:24

Plenty to look forward to ..

[rambutan2] 26/6/2024 14:11

LYT-100 phase 2 trial topline results due in 4th quarter. IPF is a big and very underserved mkt, so...

[ashkv] 26/6/2024 13:31

Big catalyst in Q3 for PRTC which will unlock $400mn in future royalties for the treatment!!!

Bristol Myers wouldn't have paid the price unless they were 99.99% confident of the below going through :)

Will accumulate at bargain levels :)

"KarXT is also in advanced testing as an adjunctive therapy to existing schizophrenia drugs and as a potential treatment for psychosis in patients with Alzheimer’s disease.

The FDA is expected to make a decision on its use in schizophrenia by Sept. 26 of next year."

[ohisay] 26/6/2024 13:27

Surprised Baron sold these but at what price ??

He was holding these pre tender offer so if I was him I'd be buying again at these levels .

Daily RSI just gone sub 20 so I just topped up at 187p,they will for sure do more buybacks I think .

Happy to hold .!

[ashkv] 26/6/2024 13:21

It appears the duke is clueless about PRTC!!! At 186p 84% Net Cash (156p)

2) There was just a tender offer that concluded for $100mn at 250p!!!

Also please note $50mn Buyback - expect a new programme to be announced soon!!!

"This completes the Share Buyback Programme of up to $50 million, details of which were announced on 9 May 2022. Between 9 May 2022 and 7 February 2024, the Company repurchased an aggregate of 20,182,863 ordinary shares under the Share Buyback Programme, which represents approximately 7% of the Company's issued share capital at the time the programme commenced. The Company intends to update its capital return strategy in light of the expected closing of the pending merger between its Founded Entity, Karuna Therapeutics, Inc. (Nasdaq: KRTX), and Bristol Meyers Squibb (NYSE: BMY)"

2theduke26 Jun '24 - 13:58 - 2093 of 2093
0 0 0
I don’t buy in to the cash to ev comparison any more. 2 primarily reasons
1) it assumes the owners give the equity holders the cash
2) it assumes they don’t have decent cash drains , such as acquisitions or r&d
I think they’ve now proved on 1) that general shareholders aren’t going to get dividends easy.
I see 1.7 , which hopefully holds

[2theduke] 26/6/2024 12:58

I don’t buy in to the cash to ev comparison any more. 2 primarily reasons
1) it assumes the owners give the equity holders the cash
2) it assumes they don’t have decent cash drains , such as acquisitions or r&d
I think they’ve now proved on 1) that general shareholders aren’t going to get dividends easy.
I see 1.7 , which hopefully holds